↓ Skip to main content

Cochrane Database of Systematic Reviews

Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients

Overview of attention for article published in Cochrane database of systematic reviews, October 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter
wikipedia
1 Wikipedia page

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
156 Mendeley
Title
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients
Published in
Cochrane database of systematic reviews, October 2012
DOI 10.1002/14651858.cd007913.pub2
Pubmed ID
Authors

Peter Renner, Stefania Milazzo, Jian Ping Liu, Marcel Zwahlen, Josef Birkmann, Markus Horneber

Abstract

High-dose or dose-intensive cytotoxic chemotherapy often causes myelosuppression and severe neutropenia among cancer patients. Severe neutropenia accompanied by fever, named febrile neutropenia (FN), is the most serious manifestation of neutropenia usually requiring hospitalization and intravenous antibiotics. FN and neutropenia can lead to chemotherapy treatment delays or dose reductions, which potentially compromises the effectiveness of cancer treatment and prospects for a cure. Granulocyte-macrophage (GM) and granulocyte colony-stimulating factors (G-CSFs) are administered during chemotherapy in order to prevent or reduce the incidence or the duration of FN and neutropenia.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 156 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
Unknown 155 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 23 15%
Student > Master 20 13%
Student > Bachelor 15 10%
Other 11 7%
Student > Ph. D. Student 10 6%
Other 29 19%
Unknown 48 31%
Readers by discipline Count As %
Medicine and Dentistry 49 31%
Nursing and Health Professions 17 11%
Biochemistry, Genetics and Molecular Biology 9 6%
Agricultural and Biological Sciences 4 3%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 21 13%
Unknown 52 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 July 2016.
All research outputs
#6,277,197
of 20,710,163 outputs
Outputs from Cochrane database of systematic reviews
#8,271
of 12,109 outputs
Outputs of similar age
#50,759
of 175,003 outputs
Outputs of similar age from Cochrane database of systematic reviews
#57
of 96 outputs
Altmetric has tracked 20,710,163 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 12,109 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.4. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 175,003 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.